Terminal 4q duplication and extended 10q deletion in a preterm infant with linear growth restriction: transcriptomic evidence of disrupted developmental and metabolic pathways.

Töpfer ET, Zähringer M, Baumgartner MK, Garbe AC, Dunstheimer D, Shoukier M, Karachun O, Walden U, Daumer-Haas C, Frühwald MC, Conrad ML, Fincke VE, Johann PD, Fahlbusch FB

Open source

DOI
10.3389/fped.2026.1850899
Published
2026
Container
Frontiers in pediatrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2026.1850899,
  title = {Terminal 4q duplication and extended 10q deletion in a preterm infant with linear growth restriction: transcriptomic evidence of disrupted developmental and metabolic pathways.},
  author = {Töpfer ET and Zähringer M and Baumgartner MK and Garbe AC and Dunstheimer D and Shoukier M and Karachun O and Walden U and Daumer-Haas C and Frühwald MC and Conrad ML and Fincke VE and Johann PD and Fahlbusch FB},
  year = {2026},
  journal = {Frontiers in pediatrics},
  doi = {10.3389/fped.2026.1850899},
  url = {https://doi.org/10.3389/fped.2026.1850899}
}

RIS

TY  - JOUR
TI  - Terminal 4q duplication and extended 10q deletion in a preterm infant with linear growth restriction: transcriptomic evidence of disrupted developmental and metabolic pathways.
AU  - Töpfer ET
AU  - Zähringer M
AU  - Baumgartner MK
AU  - Garbe AC
AU  - Dunstheimer D
AU  - Shoukier M
AU  - Karachun O
AU  - Walden U
AU  - Daumer-Haas C
AU  - Frühwald MC
AU  - Conrad ML
AU  - Fincke VE
AU  - Johann PD
AU  - Fahlbusch FB
PY  - 2026
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2026.1850899
UR  - https://doi.org/10.3389/fped.2026.1850899
ER  - 

APA

ET, T., M, Z., MK, B., AC, G., D, D., M, S., O, K., U, W., C, D., MC, F., ML, C., VE, F., PD, J., & FB, F. (2026). Terminal 4q duplication and extended 10q deletion in a preterm infant with linear growth restriction: transcriptomic evidence of disrupted developmental and metabolic pathways.. Frontiers in pediatrics. https://doi.org/10.3389/fped.2026.1850899

Source records